 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Becton Dickinson Looks to Serve Several Market Segments as it Builds Out Molecular Testing Pipeline
January 03, 2013
Becton Dickinson Looks to Serve Several Market Segments as it Builds Out Molecular Testing Pipeline
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BD Diagnostics Division Sees 5 Percent Growth in FY Q1, but MDx Not Yet a Major Driver
February 7, 2013 / PCR Insider - BD Diagnostics Execs Update Molecular Pipeline; New Tests for BD MAX and Viper on Horizon
August 9, 2012 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider - BD Diagnostics, Diagenode Launch BD Max Flu A/B Test in Europe
November 8, 2012 / PCR Insider